Cargando…
Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis
The Coronavirus Diseases-2019 (COVID-19) pandemic leads many researchers around the world to study the SARS-CoV-s2 infection and pathology to find a treatment for it. This generates a massive production of papers including pre-clinical, clinical and revisions but till now no specific treatment were...
Autor principal: | Bonavita, Andre Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577270/ https://www.ncbi.nlm.nih.gov/pubmed/33129009 http://dx.doi.org/10.1016/j.mehy.2020.110352 |
Ejemplares similares
-
Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy
por: Pan, Yu, et al.
Publicado: (2021) -
Annexin A1 Mimetic Peptide Ac(2-26) Modulates the Function of Murine Colonic and Human Mast Cells
por: Oliveira, Marcia Pereira, et al.
Publicado: (2021) -
Cellular Function of Annexin A1 Protein Mimetic Peptide Ac2-26 in Human Skin Keratinocytes HaCaT and Fibroblast Detroit 551 Cells
por: Kim, Seong Min, et al.
Publicado: (2020) -
Ac2-26, an Annexin A1 Peptide, Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury
por: Liao, Wen-I, et al.
Publicado: (2017) -
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2-26), Against Myocardial Infarction
por: Qin, Cheng Xue, et al.
Publicado: (2019)